Patents by Inventor Jeffrey Staton

Jeffrey Staton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080075658
    Abstract: The present invention is directed to a novel method for producing a radiolabeled product for use in gamma scintigraphy, preferably for use with gastric retentive formulations. One aspect of the invention is the process which comprises adsorbing a suitable radionuclide onto a substrate, such as activated charcoal, and blending this nuclide/substrate product with an insoluble polymer; forming a melt blend of the polymer mix, cooling the melt blend to form a solid, and then breaking the solid into smaller particles. Suitably, the temperature of the melt blend is high enough to melt the polymer but not enough to degrade the polymeric material.
    Type: Application
    Filed: July 19, 2007
    Publication date: March 27, 2008
    Inventors: Matthew Burke, Jeffrey Staton
  • Publication number: 20060182804
    Abstract: The present invention also relates to carvedilol free base, salts, anhydrous forms, or solvates thereof, corresponding pharmaceutical compositions or controlled release formulations, and methods delivery of carvedilol forms to the lower gastrointestingal tract or methods to treat cardiovascular diseases, which may include, but are not limited to hypertension, congestive heart failure, and angina. The present invention relates to control release formulations, which comprise various cavedilol forms, which may include, but are not limited to carvedilol free base and corresponding carvedilol salts, anhydrous forms or solvates thereof.
    Type: Application
    Filed: May 25, 2005
    Publication date: August 17, 2006
    Inventors: Matthew Burke, Mark Coffin, Kimberly Lamey, Luigi Martini, Choon Oh, Heather Peterson, Jeffrey Staton, Lihua Zhang
  • Publication number: 20050169994
    Abstract: The present invention also relates to carvedilol free base, salts, anhydrous forms, or solvates thereof, corresponding pharmaceutical compositions or controlled release formulations, and methods delivery of carvedilol forms to the lower gastrointestingal tract or methods to treat cardiovascular diseases, which may include, but are not limited to hypertension, congestive heart failure, and angina. The present invention relates to control release formulations, which comprise various cavedilol forms, which may include, but are not limited to carvedilol free base and corresponding carvedilol salts, anhydrous forms or solvates thereof.
    Type: Application
    Filed: November 24, 2004
    Publication date: August 4, 2005
    Inventors: Matthew Burke, Mark Coffin, Kimberly Lamey, Luigi Martini, Choon Oh, Heather Peterson, Jeffrey Staton, Lihua Zhang